Related references
Note: Only part of the references are listed.The Role of miRNAs in Metabolic Diseases
Mirjana Macvanin et al.
CURRENT MEDICINAL CHEMISTRY (2023)
Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia
Sergiy Sukhanov et al.
JCI INSIGHT (2023)
Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability
Arif Yurdagul
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice
Patricia Snarski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
Diagnosis of coronary artery disease: potential complications of imaging techniques
Evangelos Sdogkos et al.
ACTA CARDIOLOGICA (2022)
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis
Angelo Cignarelli et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Tryptophan Metabolism in Atherosclerosis and Diabetes
Emina Sudar-Milovanovic et al.
CURRENT MEDICINAL CHEMISTRY (2022)
Association between insulin-like growth factor-1 and cardiovascular events: a systematic review and dose-response meta-analysis of cohort studies
T. Li et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)
Insulin-like growth factor-1 levels are associated with interventricular septal thickening
Yuan Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction
Rianne Nederlof et al.
FRONTIERS IN IMMUNOLOGY (2022)
The correlation of serum/plasma IGF-1 concentrations with obstructive sleep apnea hypopnea syndrome: A meta-analysis and meta-regression
Jie He et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Insulin-like growth factor binding protein-1 regulates HIF-1α degradation to inhibit apoptosis in hypoxic cardiomyocytes
Xiaoyan Tang et al.
CELL DEATH DISCOVERY (2021)
Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports
Julian Bailes et al.
BIOMOLECULES (2021)
Vitamin D3 induces mesenchymal-to-endothelial transition and promotes a proangiogenic niche through IGF-1 signaling
Lei Chen et al.
ISCIENCE (2021)
The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth
Sarmed Al-Samerria et al.
CELLS (2021)
IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA
Sangmi Ock et al.
CELL DEATH & DISEASE (2021)
Gender Differences in the Medical Treatment of Peripheral Artery Disease
Damien Laneelle et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways
Kevin W. Huang et al.
IJC HEART & VASCULATURE (2021)
A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility
Yingshui Yao et al.
ATHEROSCLEROSIS (2020)
IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway
Mingzhuo Lin et al.
STEM CELL RESEARCH & THERAPY (2020)
Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide
Hai-Jian Sun et al.
FRONTIERS IN PHARMACOLOGY (2020)
Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell
Shailly Varma Shrivastav et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
IGF-1 and cardiometabolic diseases: a Mendelian randomisation study
Susanna C. Larsson et al.
DIABETOLOGIA (2020)
Abnormal Microvascular Architecture, Fibrosis, and Pericyte Characteristics in the Calf Muscle of Peripheral Artery Disease Patients with Claudication and Critical Limb Ischemia
Constance J. Mietus et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Endothelial deficiency of insulin-like growth factor-1 receptor reduces endothelial barrier function and promotes atherosclerosis in Apoe-deficient mice
Yusuke Higashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Peripheral Circulation and Astrocytes Contribute to the MSC-Mediated Increase in IGF-1 Levels in the Infarct Cortex in a dMCAO Rat Model
Xiaobo Li et al.
STEM CELLS INTERNATIONAL (2020)
Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes
Bozidarka L. Zaric et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of acid-labile subunit (ALS) in the modulation of GH-IGF-I action
Sabina Domene et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
IGF-1 and cardiovascular disease
Yusuke Higashi et al.
GROWTH HORMONE & IGF RESEARCH (2019)
Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis
Malin C. Erlandsson et al.
BMC MEDICINE (2019)
The role of smooth muscle cells in plaque stability: Therapeutic targeting potential
Jennifer L. Harman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
PAPP-A and the IGF system in atherosclerosis: what's up, what's down?
Lasse B. Steffensen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2019)
A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes
Gagan D. Flora et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Effects of IGF-1 on the Cardiovascular System
Milan Obradovic et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Involvement of endothelial nitric oxide synthase pathway in IGF-1 protects endothelial progenitor cells against injury from oxidized LDLs
Hao-Jing Wen et al.
MOLECULAR MEDICINE REPORTS (2019)
Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor
Lin Xihua et al.
TRANSLATIONAL RESEARCH (2019)
The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes
Natalie J. Haywood et al.
MOLECULAR METABOLISM (2019)
Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy
Sara Tellatin et al.
ATHEROSCLEROSIS (2018)
Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer
Amit Oza et al.
GYNECOLOGIC ONCOLOGY (2018)
IGF-1 receptor cleavage in hypertension
Selma Cirrik et al.
HYPERTENSION RESEARCH (2018)
How ligand binds to the type 1 insulin-like growth factor receptor
Yibin Xu et al.
NATURE COMMUNICATIONS (2018)
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
John B. Allard et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Current IGFBP-Related Biomarker Research in Cardiovascular Disease-We Need More Structural and Functional Information in Clinical Studies
Andreas Hoeflich et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Paolo Raggi et al.
ATHEROSCLEROSIS (2018)
Nitric oxide and CaMKII: Critical steps in the cardiac contractile response TO IGF-1 and swim training
Juan I. Burgos et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice
Rui Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
The Effects of IGF-1 on TNF-α-Treated DRG Neurons by Modulating ATF3 and GAP-43 Expression via PI3K/Akt/S6K Signaling Pathway
Lei Zhang et al.
NEUROCHEMICAL RESEARCH (2017)
Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke The Framingham Study
Hamidreza Saber et al.
STROKE (2017)
Insulin-Like Growth factor 1: At the crossroads of brain development and aging
Sarah Wrigley et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Regulation of Na+/K+-ATPase by Estradiol and IGF-1 in Cardio-Metabolic Diseases
Milan Obradovic et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
IGF-1 promotes angiogenesis in endothelial cells/adipose-derived stem cells co-culture system with activation of PI3K/Akt signal pathway
Shiyu Lin et al.
CELL PROLIFERATION (2017)
Diabetes in Patients With Acromegaly
A. M. Hannon et al.
CURRENT DIABETES REPORTS (2017)
IGF-1 and Insulin Resistance Are Major Determinants of Common Carotid Artery Thickness in Morbidly Obese Young Patients
Anca Sirbu et al.
ANGIOLOGY (2016)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study
Dagmar Drogan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice
Yusuke Higashi et al.
CIRCULATION (2016)
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Valentine M. Macaulay et al.
CLINICAL CANCER RESEARCH (2016)
Insulin-like growth factor-1 in early-onset coronary artery disease: Insights into the pathophysiology of atherosclerosis
Andrea De Lorenzo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo
Yanick Fanton et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1
Chun-Li Song et al.
ONCOTARGET (2016)
Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a Black population: A five-year prospective study
Aletta E. Schutte et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias
Samuel Gusscott et al.
PLOS ONE (2016)
The Prevalence of Metabolic Syndrome in Coronary Artery Disease Patients
Farzaneh Montazerifar et al.
CARDIOLOGY RESEARCH (2016)
Rheumatic Heart Disease: Causes, Symptoms, and Treatments
Min Liu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors
Robin L. Jones et al.
CLINICAL CANCER RESEARCH (2015)
GH and the cardiovascular system: an update on a topic at heart
Jorgen Isgaard et al.
ENDOCRINE (2015)
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness
Pietro Ameri et al.
ATHEROSCLEROSIS (2014)
MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis
Song Gao et al.
ATHEROSCLEROSIS (2014)
Revisiting the Relationship Between Blood Pressure and Insulin- Like Growth Factor-1
Aletta Elisabeth Schutte et al.
HYPERTENSION (2014)
Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5′ Stem-loop of COL1a1 and COL1a2 mRNA
Christopher D. Blackstock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Chemerin levels as predictor of acute coronary events: A case-control study nested within the veterans affairs normative aging study
Konstantinos N. Aronis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study
Grazina Urbonaviciene et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2014)
miRNAs: Their discovery, biogenesis and mechanism of action
N. Tetreault et al.
CLINICAL BIOCHEMISTRY (2013)
Insulin and IGF-I Inhibit GH Synthesis and Release in Vitro and in Vivo by Separate Mechanisms
Manuel D. Gahete et al.
ENDOCRINOLOGY (2013)
Cardiovascular involvement in patients affected by acromegaly: An appraisal
Susanna Mosca et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
An Integrin Binding-defective Mutant of Insulin-like Growth Factor-1 (R36E/R37E IGF1) Acts as a Dominant-negative Antagonist of the IGF1 Receptor (IGF1R) and Suppresses Tumorigenesis but Still Binds to IGF1R
Masaaki Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations
Darlene E. Berryman et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond
Stephane E. Castel et al.
NATURE REVIEWS GENETICS (2013)
The IGF-1 receptor and regulation of nitric oxide bioavailability and insulin signalling in the endothelium
V. Kate Gatenby et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs
Xiaofeng Yu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation
Jing Wang et al.
ATHEROSCLEROSIS (2012)
Energy-preserving effects of IGF-1 antagonize starvation-induced cardiac autophagy
Rodrigo Troncoso et al.
CARDIOVASCULAR RESEARCH (2012)
Insulin-like growth factor axis and risk of type 2 diabetes in women
Swapnil N. Rajpathak et al.
DIABETES (2012)
The Association Between IGF-I and Insulin Resistance A general population study in Danish adults
Nele Friedrich et al.
DIABETES CARE (2012)
Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes
David R. Clemmons
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Circulating Vascular Growth Factors and Central Hemodynamic Load in the Community
Justin P. Zachariah et al.
HYPERTENSION (2012)
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
Juan E. Puche et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Kim J. Png et al.
NATURE (2012)
The Insulin-Like Growth Factor System, Metabolic Syndrome, and Cardiovascular Disease Risk
Abayomi O. Akanji et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2012)
IGF-1 Has Plaque-Stabilizing Effects in Atherosclerosis by Altering Vascular Smooth Muscle Cell Phenotype
Jan H. von der Thuesen et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice
Shaw-Yung Shai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: The PRIME study
J. B. Ruidavets et al.
ATHEROSCLEROSIS (2011)
The Lin28/let-7 Axis Regulates Glucose Metabolism
Hao Zhu et al.
CELL (2011)
Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP)
Elisabeth Spilcke-Liss et al.
CLINICAL ENDOCRINOLOGY (2011)
Reactive Oxygen Species Play an Essential Role in IGF-I Signaling and IGF-I-Induced Myocyte Hypertrophy in C2C12 Myocytes
Anastasia-Evi Handayaningsih et al.
ENDOCRINOLOGY (2011)
Prediction of incident diabetes mellitus by baseline IGF1 levels
Harald Joern Schneider et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
MicroRNA-126 inhibits ischemia-induced retinal neovascularization via regulating angiogenic growth factors
Yanyan Bai et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
The Representative Porcine Model for Human Cardiovascular Disease
Yoriyasu Suzuki et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic women
Luxia Zhang et al.
JOURNAL OF HYPERTENSION (2011)
Duplicated zebrafish insulin-like growth factor binding protein-5 genes with split functional domains: evidence for evolutionarily conserved IGF binding, nuclear localization, and transactivation activity
Wei Dai et al.
FASEB JOURNAL (2010)
A Significant Decline in IGF-I May Predispose Young Africans to Subsequent Cardiometabolic Vulnerability
Aletta E. Schutte et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Enhanced Matrix Metalloproteinase Activity in the Spontaneously Hypertensive Rat: VEGFR-2 Cleavage, Endothelial Apoptosis, and Capillary Rarefaction
Edward D. Tran et al.
JOURNAL OF VASCULAR RESEARCH (2010)
AMP-Activated Protein Kinase Inhibits IGF-I Signaling and Protein Synthesis in Vascular Smooth Muscle Cells via Stimulation of Insulin Receptor Substrate 1 S794 and Tuberous Sclerosis 2 S1345 Phosphorylation
Junyu Ning et al.
MOLECULAR ENDOCRINOLOGY (2010)
Mammalian microRNAs predominantly act to decrease target mRNA levels
Huili Guo et al.
NATURE (2010)
Insulin-like growth factor-1 and childhood cancer risk
Mohamed Badr et al.
ONCOLOGY LETTERS (2010)
Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological Conditions
Leonardo Elia et al.
CIRCULATION (2009)
CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR-320 IN INSULIN-RESISTANT 3T3-L1 ADIPOCYTES
Hong-Yan Ling et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach
Rongshi Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M. Carboni et al.
MOLECULAR CANCER THERAPEUTICS (2009)
IGF-1 Expression in Infarcted Myocardium and MGF E Peptide Actions in Rat Cardiomyocytes in Vitro
Anastasia Stavropoulou et al.
MOLECULAR MEDICINE (2009)
The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: Findings from the prospective British Women's Heart and Health Study
Debbie A. Lawlor et al.
ATHEROSCLEROSIS (2008)
Regulation of IGF-I function by proinflammatory cytokines: At the interface of immunology and endocrinology
Jason C. O'Connor et al.
CELLULAR IMMUNOLOGY (2008)
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb
Gregorio Brevetti et al.
CLINICAL ENDOCRINOLOGY (2008)
Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects
Elena Succurro et al.
DIABETES CARE (2008)
Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects
Annamaria Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Proteinase activity and receptor cleavage -: Mechanism for insulin resistance in the spontaneously hypertensive rat
Frank A. DeLano et al.
HYPERTENSION (2008)
IGF-1 Receptor Inhibitors in Clinical Trials-Early Lessons
S. John Weroha et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Widespread changes in protein synthesis induced by microRNAs
Matthias Selbach et al.
NATURE (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice
Sergiy Sukhanov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
MicroRNA targeting specificity in mammals: Determinants beyond seed pairing
Andrew Grimson et al.
MOLECULAR CELL (2007)
Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury
Xi-Lin Niu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet
Sean C. Harrington et al.
CIRCULATION RESEARCH (2007)
Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue -: Mechanism for growth hormone-mediated insulin resistance
Juan-Pablo del Rincon et al.
DIABETES (2007)
Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke
Robert C. Kaplan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults
K. C. J. Yuen et al.
DIABETES OBESITY & METABOLISM (2007)
Diagnosis and treatment of deep-vein thrombosis
Dimitrios Scarvelis et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
Intravenous insulin-like growth factor-I receptor antisense treatment reduces angiotensin receptor expression and function in spontaneously hypertensive rats
Tien Thuy Nguyen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis
Murray C. H. Clarke et al.
NATURE MEDICINE (2006)
Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process
Martin L. Adamo et al.
AGEING RESEARCH REVIEWS (2006)
Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes
Ettore Capoluongo et al.
CYTOKINE (2006)
Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus
Patricia Pennisi et al.
ENDOCRINOLOGY (2006)
Increased p85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess
LA Barbour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke
SP Johnsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Skeletal muscle hypertrophy and atrophy signaling pathways
DJ Glass
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts
Y Min et al.
GUT (2005)
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age
A Colao et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2005)
Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis
S Kawachi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats
RW McCallum et al.
JOURNAL OF HYPERTENSION (2005)
Plasma concentration of IGE-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance
G Sesti et al.
DIABETES CARE (2005)
In vivo antitumor activity of NVP-AEW541 -: A novel, potent, and selective inhibitor of the IGF-IR kinase
C García-Echeverría et al.
CANCER CELL (2004)
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels
P Delafontaine et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Muscle-specific overexpression of CD36 reverses the insulin resistance and diabetes of MKR mice
L Héron-Milhavet et al.
ENDOCRINOLOGY (2004)
Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam study)
GS Bleumink et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study
GA Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes
M Dehoux et al.
ENDOCRINOLOGY (2004)
Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men - The CARDIA Male Hormone Study
LA Colangelo et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Insulin-like growth factor-1 as a vascular protective factor
E Conti et al.
CIRCULATION (2004)
Loss of tumorigenicity and metastatic potential in carcinoma cells expressing the extracellular domain of the type 1 insulin-like growth factor receptor
AA Samani et al.
CANCER RESEARCH (2004)
Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study
RS Vasan et al.
ANNALS OF INTERNAL MEDICINE (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript
EA Bohula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury
R Hutter et al.
CIRCULATION (2003)
Endogenous hormones and carotid atherosclerosis in elderly men
AW van den Beld et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase/Akt signaling pathway
YX Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Structural biology of insulin and IGF1 receptors: Implications for drug design
P De Meyts et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease - A population-based case-control study
A Juul et al.
CIRCULATION (2002)
Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness
D Le Roith et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2002)
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase
S Favelyukis et al.
NATURE STRUCTURAL BIOLOGY (2001)
Functional inactivation, of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes
AM Fernández et al.
GENES & DEVELOPMENT (2001)
Role of PI3-kinase in isoproterenol and IGF-1 induced ecNOS activity
E Isenovic et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism
K Sjögren et al.
DIABETES (2001)
Impaired insulin-like growth factor I vasorelaxant effects in hypertension
C Vecchione et al.
HYPERTENSION (2001)
Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle - Characterization of the signaling pathway
J Du et al.
CIRCULATION RESEARCH (2001)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity
S Yakar et al.
DIABETES (2001)
Structure and function of the type 1 insulin-like growth factor receptor
TE Adams et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
The insulin-like growth factor axis - A review of atherosclerosis and restenosis
A Bayes-Genis et al.
CIRCULATION RESEARCH (2000)
Insulin and insulin-like growth factor-I cause vasorelaxation in human vessels in vitro
U Izhar et al.
CORONARY ARTERY DISEASE (2000)
Insulin-like growth factor binding protein-4 expression is decreased by angiotensin II and thrombin in rat aortic vascular smooth muscle cells
A Anwar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
